peaks during dose escalation, typically mild-moderate Diarrhea -- 10-20%, usually transient Constipation -- 8-15% Vomiting -- 5-15%, more frequent at higher doses Injection site reactions -- 5-10%, mild erythema and pruritus Decreased appetite -- 5-12%, related to mechanism of action Pancreatitis -- rare but monitored (as with all GLP-1/amylin agents) Gallbladder events -- cholelithiasis reported, consistent with rapid weight loss Trial data describes dose titration as central to tolerability -- the 16-week escalation protocol substantially reduced GI adverse events
Each medication has its recommended starting dose, which is usually adjusted gradually
A new authorization is required if you switch to a different covered GLP-1 medication
These individuals were allocated randomly into the intervention and control groups
Prince is highly regarded as one of the best plastic surgeons in Kerala for administering glutathione shots for skin whitening
Even outside the context of GLP-1s, disruptions in temperature regulation and menstrual function can make exercise feel harder than usual